Weekly Rewinds

Weekly summaries of the top medical research

2 Minute Medicine Rewind

In this section, we will highlight the some of the key high-impact studies, updates, and analyses published in the past week. ADVANCE III Trial: Effect...

2 Minute Medicine Rewind: May 13 – May 19

May 13 – 19, 2013 In this section, we will highlight the some of the recent high-impact studies, updates, and analyses published in the past...

2 Minute Medicine Rewind: May 20 – May 27

May 20 - 27, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during the...

2 Minute Medicine Rewind: June 1 – June 9

June 1 – June 9, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during...

2 Minute Medicine Rewind: June 10 – June 17

June 10 – June 17, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during...

2 Minute Medicine Rewind June 17- June 24

June 17 – June 24, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during...

2 Minute Medicine Rewind June 24 – June 30

Image: PD June 24 – June 30, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine...

2 Minute Medicine Rewind: July 1 – July 7

In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during the past week. Urinary-Cell mRNA Profile...

2 Minute Medicine Rewind July 8 – July 14, 2013

Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Geographic Variation in Cardiovascular...

2 Minute Medicine Rewind: July 15 – July 21, 2013

Image: PD. West Nile Virus In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Targeting...
licensing as small

All-time hits